Cephalon raises 2Q earnings, sales expectations – BusinessWeek
By Dr. Matthew Watson
 RTT News | Cephalon raises 2Q earnings, sales expectations BusinessWeek Biotechnology company Cephalon Inc. said Wednesday strong product sales will push its second-quarter earnings per share higher than it anticipated. ... Cephalon says 2Q stronger than anticipatedPhiladelphia Business Journal Cephalon Expects Second Quarter 2010 Results to Exceed Previously Issued GuidancePR Newswire (press release) |
Uncategorized
Comments Off on Cephalon raises 2Q earnings, sales expectations – BusinessWeek |
July 22nd, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research